BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1710673)

  • 1. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.
    Levine AM; Wernz JC; Kaplan L; Rodman N; Cohen P; Metroka C; Bennett JM; Rarick MU; Walsh C; Kahn J
    JAMA; 1991 Jul; 266(1):84-8. PubMed ID: 1710673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
    Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
    Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma.
    Canellos GP; Skarin AT; Klatt MM; Rosenthal DS; Case DC; Pinkus GS; Jochelson MS; Yeap BY; Shipp MA
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):2-7. PubMed ID: 2438777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
    Shipp MA; Yeap BY; Harrington DP; Klatt MM; Pinkus GS; Jochelson MS; Rosenthal DS; Skarin AT; Canellos GP
    J Clin Oncol; 1990 Jan; 8(1):84-93. PubMed ID: 1688615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS-related malignant lymphoma: results of prospective treatment trials.
    Gill PS; Levine AM; Krailo M; Rarick MU; Loureiro C; Deyton L; Meyer P; Rasheed S
    J Clin Oncol; 1987 Sep; 5(9):1322-8. PubMed ID: 2442321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
    Gisselbrecht C; Oksenhendler E; Tirelli U; Lepage E; Gabarre J; Farcet JP; Gastaldi R; Coiffier B; Thyss A; Raphael M
    Am J Med; 1993 Aug; 95(2):188-96. PubMed ID: 7689296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Kaplan LD; Straus DJ; Testa MA; Von Roenn J; Dezube BJ; Cooley TP; Herndier B; Northfelt DW; Huang J; Tulpule A; Levine AM
    N Engl J Med; 1997 Jun; 336(23):1641-8. PubMed ID: 9171066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
    Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.
    Straus DJ; Huang J; Testa MA; Levine AM; Kaplan LD
    J Clin Oncol; 1998 Nov; 16(11):3601-6. PubMed ID: 9817281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant lymphomas in HIV-infected patients].
    Adam H; Flepp M; Schüler G; Egli F; Greminger P; Lüthy R; Rhyner K
    Schweiz Med Wochenschr; 1988 Nov; 118(45):1651-6. PubMed ID: 2460919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
    Skarin AT; Canellos GP; Rosenthal DS; Case DC; MacIntyre JM; Pinkus GS; Moloney WC; Frei E
    J Clin Oncol; 1983 Feb; 1(2):91-8. PubMed ID: 6199472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
    Sawka CA; Shepherd FA; Franssen E; Brandwein J; Dotten DA; Routy JP; Walker IR; St-Louis J; Taylor M; Arts K; Crump M; Foote M
    Biotechnol Annu Rev; 2005; 11():381-9. PubMed ID: 16216784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
    Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
    Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase III comparative trial of m-BACOD vs m-BNCOD in the treatment of stage II-IV diffuse non-Hodgkin's lymphomas.
    Guglielmi C; Gherlinzoni F; Amadori S; Mazza P; Mantovani L; Lauria F; Martelli M; Zinzani PL; Greco V; Poletti G
    Haematologica; 1989; 74(6):563-9. PubMed ID: 2483401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
    Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial.
    Dana BW; Dahlberg S; Miller TP; Hartsock RJ; Balcerzak S; Coltman CA; Carden JO; Hartley K; Fisher RI
    J Clin Oncol; 1990 Jul; 8(7):1155-62. PubMed ID: 1694233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Miles SA; Mitsuyasu RT; Montgomery T; McCarthy S; Espina BM; Feldstein M; Levine AM
    AIDS; 1994 Dec; 8(12):1695-9. PubMed ID: 7534090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy.
    Shipp MA; Klatt MM; Yeap B; Jochelson MS; Mauch PM; Rosenthal DS; Skarin AT; Canellos GP
    J Clin Oncol; 1989 May; 7(5):613-8. PubMed ID: 2468746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.